Active Ingredient(s): Angiotensin II
FDA Approved: * December 21, 2017
Pharm Company: * LA JOLLA PHARM CO
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Giapreza Overview

2WXW, 2X0B, 4APH,%%s1N9U, 1N9V,%%s1N9V, 1N9U, 3CK0, 4AA1, 4APH, 5E2QIdentifiersAliasesAGT, ANHU, SERPINA8, hFLT1, angiotensinogenExternal IDsMGI: 87963 HomoloGene: 14 GeneCards: AGT Gene location (Human)Chr.Chromosome 1 (human)[1]Band1q42.2Start230,690,776 bp[1]End230,745,576 bp[1]Gene location (Mouse)Chr.Chromosome 8 (mouse)[2]Band8 E2|8 72.81 cMStart124,556,534 bp[2]End124,569,706 bp[2]R...

Read more Giapreza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Giapreza Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Angiotensin II
  • Solution: 2.5mg/ml (2.5mg/ml), 5mg/2ml (2.5mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Giapreza: (1 result)

Sorted by National Drug Code
  • 68547-501 Giapreza 2.5 mg/ml Intravenous Injection by La Jolla Pharmaceutical Company

Other drugs which contain Angiotensin II or a similar ingredient: (1 result)